HER-2/Epstein-Barr virus crosstalk in human gastric carcinogenesis: A novel concept of oncogene/oncovirus interaction

Epstein-Barr virus strains and variations: Geographic or disease-specific variants?

(2016) Marco Neves et al.   JOURNAL OF MEDICAL VIROLOGY

Gastric cancer

(2016) Eric Van Cutsem et al.   LANCET

Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery

(2016) A Dokala et al.   ONCOGENE

Management of advanced gastric cancer: An overview of major findings from meta-analysis

(2016) Xiaolong Qi et al.   Oncotarget

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

(2016) Valentina Fanotto et al.   Oncotarget

Epstein–Barr Virus Infection and Gastric Cancer

(2015) Xin-Zu Chen et al.   MEDICINE

Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas

(2015) Yi-wang Zhang et al.   Oncotarget

EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN

(2014) L-M Cai et al.   ONCOGENE

Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile

(2012) Weihua Tang et al.   Infectious Agents and Cancer

The Lytic Phase of Epstein-Barr Virus Requires a Viral Genome with 5-Methylcytosine Residues in CpG Sites

(2011) M. Kalla et al.   JOURNAL OF VIROLOGY

High-Risk HPV/ErbB-2 Interaction on E-Cadherin/Catenin Regulation in Human Carcinogenesis

(2008) Ala-Eddin Al Moustafa et al.   CURRENT PHARMACEUTICAL DESIGN